Navigation Links
Special Summer Camp Helps Girls Recognize Inner and Outer Beauty
Date:8/20/2008

rthoNeutrogena(R)

OrthoNeutrogena(R), the dermatology-specialty division of Johnson & Johnson, is a leader in delivering novel therapies that address the multiple needs of dermatologists and their patients. A pioneer in treatment areas that span from acne and infection to aesthetics and photodamage, OrthoNeutrogena continues to demonstrate an unwavering commitment to the dermatology community. OrthoNeutrogena dermatology products include: RETIN-A MICRO(R) PUMP, ERTACZO(R), BIAFINE(R), RENOVA(R) and Grifulvin V(R).

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 1, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov or on request from Johnson & Johnson. Johnson & Johnson assumes no obligation to update any forward-looking statements as a result of new information or future events or developments.)

About ELLEgirl.com

ELLEgirl.com provides young women with insider information on fashion, beauty, service
'/>"/>

SOURCE OrthoNeutrogena
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
2. Specialty Surgery Center to Partner With Surgical Care Affiliates
3. The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14
4. Whos Who Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets, Wont Accept Compensation From Anyone, Sending Complete Guide Free to All
5. The Journal of Allergy and Clinical Immunology devotes special issue to AIDS
6. Most Influential Events for Koreas Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November
7. Alzheimers Treatment Trials May Have Special Challenges
8. Florida Dentist Launches Revolutionary Solution to National Dental Specialist/Patient Care Dilemma
9. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
10. California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists Support for Same-Sex Couples
11. More Cancer Lymph Nodes Analyzed at Specialty Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... team of researchers from Monash University, The B...cal School and Vanda Pharmaceuticals has found a n...d sleep disorders caused by shift work. , Dr Sh...f Psychology, Psychiatry and Psychological Medicin... receptors in the brain, could be a highly effecti...
(Date:12/2/2008)..., members of SEIU 721, Ask for an Injunction in Fe...ERSIDE, Calif., Dec. 2 ...the Riverside County Regional Medical Center, file...awsuit in federal court Monday to stop the county ... , , Three nurses, who are seeking to repre...
(Date:12/2/2008)... COLUMBIA, Mo. The statistics for sexual assault... that one in five college women will be the victim...r college years. In a new study, researchers from ...ouri, have found that college women often are unaw... recognize the risk of certain behaviors, includin...
(Date:12/2/2008)... (Embargoed for Tuesday, December 2, 2008 at 3 pm...om the Medical University of South Carolina in Cha...he risk of cancer from exposure to radiation durin...as been overstated and that new estimates are seve...ons. The MUSC researchers presented their finding...
Breaking Medicine News(10 mins):Health News:New medication brings hope of jet lag cure 2Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2
...ght out its version of bird flu, a blur of fact an...ublic//. "Fatal Contact: Bird Flu in America," an...s scientists are to begin testing of wild birds in...f bird flu in North America. Scientists fear the b...
...ted to analyze the incidence of adverse drug react...ore common in blacks and those of an East Asian or...British Medical Journal. The results of the prese... ethnicity may play a crucial role in determining ...
... University of Michigan Kellogg Eye Center have be...velops into a mature one and then goes about doing...o catch the cell when it had been assigned a parti...ing up to do it. The study also looked at the rol...
...dy conducted by The Royal College of Midwives has ...o stay out of the labor room//. Nearly 38% of the ...mebody else in the delivery room. Surprisingly, o... delivery room felt that they were useless during ...
Other Medicine News:Health News:Bird Flu: Fact or Fiction 2Health News:Bird Flu: Fact or Fiction 3Health News:The ABC Of Photoreceptors In The Eye 2
(Date:12/1/2008)...te Ltd today announced the initiation of a Phase 1...ctive JAK2 inhibitor, in leading medical centers i...yelofibrosis (CIMF). , , The trial is desi...1518 in patients with CIMF and is expected to enro...y will assess the safety profile and evaluate the ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3The impact of physical activity on weight bearing knee joint 2297 1The impact of physical activity on weight bearing knee joint 2297 2The impact of physical activity on weight bearing knee joint 2297 3Babies raised in bilingual homes learn new words differently than infants learning one language 2295 1Babies raised in bilingual homes learn new words differently than infants learning one language 2295 2Babies raised in bilingual homes learn new words differently than infants learning one language 2295 3Painful condition affecting kidney failure patients increases risk of death 2293 1Painful condition affecting kidney failure patients increases risk of death 2293 2Painful condition affecting kidney failure patients increases risk of death 2293 3APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 1APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 2
... WIRE)--Mar 26, 2007 - Inovio Biomedical Corp.,(AM...A vaccines and,a novel solid tumor ablation therap...s published a scientific paper prepared by,Inovio,...om a,non-human primate study of an investigational...omedical,s electroporation technology.,The paper, ...
...Outpatient Infusion Study in Patients with,Chronic...ican,College of Cardiology 56th Annual Scientific ... March 25, 2007,/PRNewswire/ -- Scios Inc. announc... study of nesiritide (NATRECOR(R)) showed a,neutra...eath and,cardiorenal hospitalization at 12 weeks, ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7
...fely, the Hoefer GD 2000 uses a dry-heat vacuum me...through a heavy aluminum platen. , Dries acrylami...as thirty minutes., The heavy aluminum platen prov...bution under the gel., A clear silicone cover shee...
...ilizes a hot air drying device for polyacrylamide ...g frames at once. Gels are dried on a clear cellop...is recessed to provide a smooth, flat assembly sur...m includes a gel drying oven, 2 drying frames, 16 ...
The PRO6000 power supply is the latest edition to Thermo's power supply product offering. It sets new standards in proteomic and genomic electrophoresis. This product has unique features dedicated to
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus.
Medicine Products: